Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ACADIA PHARMACEUTICALS INC Director's Dealing 2021

Dec 20, 2021

31237_dirs_2021-12-20_37f00190-ba87-46da-94fa-434a81a15bb8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2021-12-09

Reporting Person: Schneyer Mark C. (Chief Financial Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1303 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (Right to Buy) $46.81 2030-06-07 Common Stock (41066) Direct
Employee Stock Option (Right to Buy) $49.74 2031-02-22 Common Stock (19927) Direct
Restricted Stock Units $ Common Stock (5679) Direct
Restricted Stock Units $ Common Stock (5411) Direct
Restricted Stock Units $ Common Stock (39651) Direct
Restricted Stock Units $ Common Stock (39651) Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vested and became exercisable on June 8, 2021, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

F2: 25% of the shares subject to the Stock Option vest and become exercisable on February 23, 2022, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

F3: One-third of the shares subject to the restricted stock units vest on each of June 8, 2022, June 8, 2023 and June 8, 2024.

F4: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5: The restricted stock units vest in four equal annual installments beginning February 23, 2022.

F6: The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date.

F7: The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period.